Edition:
United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

6.41USD
21 Sep 2018
Change (% chg)

$-0.16 (-2.44%)
Prev Close
$6.57
Open
$6.59
Day's High
$6.60
Day's Low
$6.29
Volume
3,285,631
Avg. Vol
407,835
52-wk High
$9.41
52-wk Low
$5.03

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.19 December 22 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 3 3 3
(2) OUTPERFORM 2 1 1 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.25 1.25 1.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 4 4.12 4.20 4.08 30.80
Quarter Ending Dec-18 4 10.03 16.83 4.80 37.80
Year Ending Dec-18 4 21.30 27.92 16.40 60.80
Year Ending Dec-19 4 71.23 90.40 39.62 101.71
Earnings (per share)
Quarter Ending Sep-18 4 -0.19 -0.17 -0.19 0.12
Quarter Ending Dec-18 4 -0.14 -0.06 -0.20 0.20
Year Ending Dec-18 4 -0.71 -0.59 -0.78 -0.37
Year Ending Dec-19 4 -0.22 -0.05 -0.49 0.15

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 3.67 3.88 0.21 5.74
Quarter Ending Mar-18 4.35 3.19 1.16 26.69
Quarter Ending Dec-17 3.20 3.89 0.69 21.53
Quarter Ending Sep-17 3.52 2.70 0.82 23.38
Quarter Ending Jun-17 3.67 2.77 0.91 24.76

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 4.12 4.16 4.18 6.36 30.80
Quarter Ending Dec-18 10.03 10.07 11.83 14.19 37.80
Year Ending Dec-18 21.30 21.30 23.09 27.40 60.80
Year Ending Dec-19 71.23 71.22 77.93 80.02 101.71

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 1 0 1
Quarter Ending Dec-18 0 1 0 1
Year Ending Dec-18 1 0 0 1
Year Ending Dec-19 1 0 0 3
Earnings